title: Do patients prefer transdermal fentanyl or sustained-release oral morphine for treatment of chronic non-cancer pain?
authors.affiliation: Mercy Family Medicine, Saint Louis, MO, USA. heidaj@stlo.smhs.com
authors.forename: A J
authors.initials: AJ
authors.lastname: Heidemann
authors.forename: T L
authors.initials: TL
authors.lastname: Seaton
mesh_terms: D000279:Administration, Cutaneous; D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000701:Analgesics, Opioid / Q000627:therapeutic use*; D002908:Chronic Disease; D018592:Cross-Over Studies; D003692:Delayed-Action Preparations; D005283:Fentanyl / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D009020:Morphine / Q000627:therapeutic use*; D015337:Multicenter Studies as Topic; D010146:Pain / Q000188:drug therapy*; D017060:Patient Satisfaction; D016032:Randomized Controlled Trials as Topic
chemical_list: D000701:Analgesics, Opioid; D003692:Delayed-Action Preparations; D009020:Morphine; D005283:Fentanyl